New blood test could spare bile duct cancer patients unnecessary surgery
NCT ID NCT06381648
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new blood test called LyMIC that looks for tiny particles (exosomes) released by cancer cells. The goal was to see if it could accurately tell whether bile duct cancer has spread to nearby lymph nodes before surgery. Researchers analyzed blood samples from 230 patients with intrahepatic cholangiocarcinoma. If successful, this test could help doctors choose the right treatment—like whether to remove lymph nodes—without needing invasive procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- LyMIC (a panel of exosomal miRNAs measured in blood)
- What this could lead to
- If this blood test proves accurate, it could help doctors decide on the best treatment approach for intrahepatic cholangiocarcinoma without needing invasive surgery to check lymph nodes.
- What could go wrong
- This is a completed study, but the test's accuracy is still being evaluated. It may not be reliable enough for routine use, and further validation in larger, diverse groups is needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHOLANGIOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91016, United States
-
Department of Gastroenterological Surgery I, Graduate School of Medicine, Hokkaido University
Hokkaido, Sapporo, 060-8648, Japan
-
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University
Fukuoka, 812-8582, Japan
-
Department of Surgery, Tokushima University
Tokushima, 770-8503, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new test could reveal how radiation affects the liver
- Can blood tests reveal how liver and bile duct cancers respond to treatment?
- Can a smart drug home in on Hard-to-Treat GI cancers?
- Can matching drugs to tumor genes beat biliary cancer?
- Can a new drug ST316 shrink Hard-to-Treat tumors?
- Web tool aims to empower rare cancer patients in genomic choices